As vaccination rates fell off a cliff during the pandemic’s first year, GSK and IQVIA are creating a platform to track how well shots are being taken up across the U.S.
That platform, known simply as Vaccine Track, has been set up to be used by public health officials, industry leaders and medical professionals to “strengthen vaccination data transparency, raise awareness and publicly share vaccination trends to aid improvements in routine adult vaccinations to create healthier communities across the U.S.,” the Big Pharma said in a press release.
As of now, Vaccine Track spans information from January 2019 to December 2021 and will be updated on a quarterly basis. It gleans data from across medical claims data and prescription data, though vaccines given in institutional or hospital settings are not accounted for.
GSK sells a host of vaccines including for hepatitis A and B, influenza, shingles, measles, mumps and rubella and rotavirus, to name but a few, and is also working on COVID vaccines.